annual CFI:
$755.56M+$921.36M(+555.70%)Summary
- As of today (May 29, 2025), SRPT annual cash flow from investing activities is $755.56 million, with the most recent change of +$921.36 million (+555.70%) on December 31, 2024.
- During the last 3 years, SRPT annual CFI has risen by +$260.15 million (+52.51%).
- SRPT annual CFI is now at all-time high.
Performance
SRPT Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$291.18M-$1.06B(-138.11%)Summary
- As of today (May 29, 2025), SRPT quarterly cash flow from investing activities is -$291.18 million, with the most recent change of -$1.06 billion (-138.11%) on March 1, 2025.
- Over the past year, SRPT quarterly CFI has dropped by -$509.97 million (-233.08%).
- SRPT quarterly CFI is now -138.11% below its all-time high of $764.12 million, reached on December 31, 2024.
Performance
SRPT quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$245.59M-$509.97M(-67.50%)Summary
- As of today (May 29, 2025), SRPT TTM cash flow from investing activities is $245.59 million, with the most recent change of -$509.97 million (-67.50%) on March 1, 2025.
- Over the past year, SRPT TTM CFI has increased by +$205.09 million (+506.38%).
- SRPT TTM CFI is now -67.50% below its all-time high of $755.56 million, reached on December 31, 2024.
Performance
SRPT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SRPT Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +555.7% | -233.1% | +506.4% |
| 3 y3 years | +52.5% | +63.0% | +154.9% |
| 5 y5 years | +163.5% | -1546.9% | +83.5% |
SRPT Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +172.2% | -138.1% | +63.0% | -67.5% | +123.2% |
| 5 y | 5-year | at high | +172.2% | -138.1% | +63.0% | -67.5% | +123.2% |
| alltime | all time | at high | +172.2% | -138.1% | +63.0% | -67.5% | +123.2% |
SRPT Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$291.18M(-138.1%) | $245.59M(-67.5%) |
| Dec 2024 | $755.56M(-555.7%) | $764.12M(-693.1%) | $755.56M(-1136.2%) |
| Sep 2024 | - | -$128.82M(+30.7%) | -$72.92M(-52.9%) |
| Jun 2024 | - | -$98.53M(-145.0%) | -$154.66M(-481.9%) |
| Mar 2024 | - | $218.80M(-440.0%) | $40.50M(-124.4%) |
| Dec 2023 | -$165.80M(-84.2%) | -$64.36M(-69.4%) | -$165.80M(+80.9%) |
| Sep 2023 | - | -$210.57M(-317.9%) | -$91.65M(-166.4%) |
| Jun 2023 | - | $96.63M(+673.6%) | $138.04M(-155.5%) |
| Mar 2023 | - | $12.49M(+27.5%) | -$248.58M(-76.3%) |
| Dec 2022 | -$1.05B(-311.3%) | $9.80M(-48.8%) | -$1.05B(-1.2%) |
| Sep 2022 | - | $19.12M(-106.6%) | -$1.06B(+0.1%) |
| Jun 2022 | - | -$289.99M(-63.1%) | -$1.06B(+136.7%) |
| Mar 2022 | - | -$785.81M(>+9900.0%) | -$447.06M(-190.2%) |
| Dec 2021 | $495.41M(-507.0%) | -$2.58M(-112.7%) | $495.41M(+32.4%) |
| Sep 2021 | - | $20.27M(-93.7%) | $374.10M(-8.3%) |
| Jun 2021 | - | $321.06M(+104.9%) | $407.91M(+675.1%) |
| Mar 2021 | - | $156.67M(-226.5%) | $52.63M(-143.2%) |
| Dec 2020 | -$121.72M(-142.5%) | -$123.89M(-329.1%) | -$121.72M(-732.3%) |
| Sep 2020 | - | $54.08M(-258.0%) | $19.25M(-136.5%) |
| Jun 2020 | - | -$34.23M(+93.6%) | -$52.78M(-139.4%) |
| Mar 2020 | - | -$17.68M(-203.5%) | $133.81M(-53.3%) |
| Dec 2019 | $286.73M(-177.4%) | $17.08M(-195.1%) | $286.73M(+798.6%) |
| Sep 2019 | - | -$17.96M(-111.8%) | $31.91M(-335.8%) |
| Jun 2019 | - | $152.37M(+12.7%) | -$13.53M(-93.9%) |
| Mar 2019 | - | $135.23M(-156.9%) | -$221.00M(-40.3%) |
| Dec 2018 | -$370.49M(+107.2%) | -$237.74M(+275.0%) | -$370.49M(-40.9%) |
| Sep 2018 | - | -$63.40M(+15.1%) | -$626.45M(+43.0%) |
| Jun 2018 | - | -$55.09M(+286.3%) | -$438.10M(+8.7%) |
| Mar 2018 | - | -$14.26M(-97.1%) | -$403.06M(+125.4%) |
| Dec 2017 | -$178.81M(+98.3%) | -$493.69M(-495.1%) | -$178.81M(-254.0%) |
| Sep 2017 | - | $124.95M(-723.1%) | $116.11M(+8307.4%) |
| Jun 2017 | - | -$20.05M(-109.6%) | $1.38M(-98.6%) |
| Mar 2017 | - | $209.99M(-205.6%) | $100.37M(-211.3%) |
| Dec 2016 | -$90.19M(-1172.4%) | -$198.77M(-2044.2%) | -$90.19M(-332.7%) |
| Sep 2016 | - | $10.22M(-87.0%) | $38.76M(-34.9%) |
| Jun 2016 | - | $78.94M(+306.4%) | $59.56M(-472.3%) |
| Mar 2016 | - | $19.42M(-127.8%) | -$15.99M(-290.2%) |
| Dec 2015 | $8.41M(-105.3%) | -$69.82M(-325.1%) | $8.41M(-93.3%) |
| Sep 2015 | - | $31.02M(+816.9%) | $124.91M(+70.3%) |
| Jun 2015 | - | $3.38M(-92.3%) | $73.35M(+9.3%) |
| Mar 2015 | - | $43.83M(-6.1%) | $67.09M(-142.2%) |
| Dec 2014 | -$159.03M(+1262.5%) | $46.68M(-327.2%) | -$159.03M(-23.0%) |
| Sep 2014 | - | -$20.54M(+614.0%) | -$206.53M(+10.1%) |
| Jun 2014 | - | -$2.88M(-98.4%) | -$187.66M(+0.8%) |
| Mar 2014 | - | -$182.29M(>+9900.0%) | -$186.24M(+1495.6%) |
| Dec 2013 | -$11.67M(+919.4%) | -$822.00K(-51.0%) | -$11.67M(+3.5%) |
| Sep 2013 | - | -$1.68M(+15.4%) | -$11.27M(+16.5%) |
| Jun 2013 | - | -$1.45M(-81.2%) | -$9.68M(+12.5%) |
| Mar 2013 | - | -$7.72M(+1725.1%) | -$8.60M(+651.4%) |
| Dec 2012 | -$1.15M(-50.3%) | -$423.00K(+422.2%) | -$1.15M(-24.0%) |
| Sep 2012 | - | -$81.00K(-78.6%) | -$1.51M(-13.7%) |
| Jun 2012 | - | -$379.00K(+44.7%) | -$1.75M(-21.8%) |
| Mar 2012 | - | -$262.00K(-66.6%) | -$2.23M(-3.2%) |
| Dec 2011 | -$2.31M(+17.5%) | -$784.00K(+145.0%) | -$2.31M(+13.7%) |
| Sep 2011 | - | -$320.00K(-63.0%) | -$2.03M(-7.7%) |
| Jun 2011 | - | -$865.00K(+157.4%) | -$2.20M(+22.6%) |
| Mar 2011 | - | -$336.00K(-33.7%) | -$1.79M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$1.96M(+4.1%) | -$507.00K(+3.7%) | -$1.96M(-19.1%) |
| Sep 2010 | - | -$489.00K(+6.3%) | -$2.42M(+7.0%) |
| Jun 2010 | - | -$460.00K(-8.9%) | -$2.27M(+8.4%) |
| Mar 2010 | - | -$505.00K(-47.9%) | -$2.09M(+10.9%) |
| Dec 2009 | -$1.88M(+52.0%) | -$969.00K(+192.7%) | -$1.88M(+39.3%) |
| Sep 2009 | - | -$331.00K(+16.5%) | -$1.35M(+12.3%) |
| Jun 2009 | - | -$284.00K(-5.0%) | -$1.20M(+1.5%) |
| Mar 2009 | - | -$299.00K(-31.6%) | -$1.19M(-4.4%) |
| Dec 2008 | -$1.24M(-111.7%) | -$437.30K(+139.4%) | -$1.24M(-114.1%) |
| Sep 2008 | - | -$182.70K(-31.3%) | $8.79M(+7.4%) |
| Jun 2008 | - | -$266.00K(-24.6%) | $8.19M(-17.5%) |
| Mar 2008 | - | -$353.00K(-103.7%) | $9.92M(-6.2%) |
| Dec 2007 | $10.58M(-632.0%) | $9.59M(-1317.1%) | $10.58M(+1563.9%) |
| Sep 2007 | - | -$788.20K(-153.6%) | $635.60K(-20.0%) |
| Jun 2007 | - | $1.47M(+390.8%) | $794.10K(-162.3%) |
| Mar 2007 | - | $299.70K(-186.4%) | -$1.27M(-35.9%) |
| Dec 2006 | -$1.99M(-81.8%) | -$346.90K(-44.9%) | -$1.99M(-81.9%) |
| Sep 2006 | - | -$629.70K(+5.3%) | -$10.98M(+17.9%) |
| Jun 2006 | - | -$597.90K(+44.6%) | -$9.31M(-16.1%) |
| Mar 2006 | - | -$413.50K(-95.6%) | -$11.10M(+1.7%) |
| Dec 2005 | -$10.92M(-152.4%) | -$9.34M(-998.1%) | -$10.92M(-278.0%) |
| Sep 2005 | - | $1.04M(-143.5%) | $6.13M(-49.0%) |
| Jun 2005 | - | -$2.39M(+938.3%) | $12.04M(-49.2%) |
| Mar 2005 | - | -$230.00K(-103.0%) | $23.70M(+13.7%) |
| Dec 2004 | $20.84M(-234.8%) | $7.71M(+11.1%) | $20.84M(+112.8%) |
| Sep 2004 | - | $6.94M(-25.2%) | $9.79M(+168.9%) |
| Jun 2004 | - | $9.28M(-399.7%) | $3.64M(-116.8%) |
| Mar 2004 | - | -$3.10M(-7.1%) | -$21.66M(+40.1%) |
| Dec 2003 | -$15.46M(+544.2%) | -$3.33M(-521.0%) | -$15.46M(+40.2%) |
| Sep 2003 | - | $791.70K(-104.9%) | -$11.03M(+26.3%) |
| Jun 2003 | - | -$16.02M(-615.5%) | -$8.73M(+782.3%) |
| Mar 2003 | - | $3.11M(+183.2%) | -$989.30K(-58.8%) |
| Dec 2002 | -$2.40M(-81.2%) | $1.10M(-64.5%) | -$2.40M(-82.3%) |
| Sep 2002 | - | $3.09M(-137.3%) | -$13.58M(-22.8%) |
| Jun 2002 | - | -$8.29M(-587.7%) | -$17.60M(+76.7%) |
| Mar 2002 | - | $1.70M(-116.8%) | -$9.96M(-22.0%) |
| Dec 2001 | -$12.77M(+1065.3%) | -$10.08M(+988.5%) | -$12.77M(+314.9%) |
| Sep 2001 | - | -$926.40K(+43.8%) | -$3.08M(+22.8%) |
| Jun 2001 | - | -$644.40K(-42.1%) | -$2.51M(+18.7%) |
| Mar 2001 | - | -$1.11M(+183.5%) | -$2.11M(+92.7%) |
| Dec 2000 | -$1.10M(+119.1%) | -$392.90K(+10.6%) | -$1.10M(+36.5%) |
| Sep 2000 | - | -$355.30K(+42.3%) | -$802.80K(+46.6%) |
| Jun 2000 | - | -$249.70K(+155.3%) | -$547.50K(+37.6%) |
| Mar 2000 | - | -$97.80K(-2.2%) | -$397.80K(-20.4%) |
| Dec 1999 | -$500.00K(-80.8%) | -$100.00K(0.0%) | -$500.00K(-16.7%) |
| Sep 1999 | - | -$100.00K(0.0%) | -$600.00K(-76.0%) |
| Jun 1999 | - | -$100.00K(-50.0%) | -$2.50M(-7.4%) |
| Mar 1999 | - | -$200.00K(0.0%) | -$2.70M(+3.8%) |
| Dec 1998 | -$2.60M(+420.0%) | -$200.00K(-90.0%) | -$2.60M(-3.7%) |
| Sep 1998 | - | -$2.00M(+566.7%) | -$2.70M(+285.7%) |
| Jun 1998 | - | -$300.00K(+200.0%) | -$700.00K(+16.7%) |
| Mar 1998 | - | -$100.00K(-66.7%) | -$600.00K(+20.0%) |
| Dec 1997 | -$500.00K(-600.0%) | -$300.00K(<-9900.0%) | -$500.00K(+150.0%) |
| Sep 1997 | - | $0.00(-100.0%) | -$200.00K(0.0%) |
| Jun 1997 | - | -$200.00K(<-9900.0%) | -$200.00K(<-9900.0%) |
| Mar 1997 | - | $0.00 | $0.00 |
| Dec 1996 | $100.00K | - | - |
FAQ
- What is Sarepta Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual CFI year-on-year change?
- What is Sarepta Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly CFI year-on-year change?
- What is Sarepta Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM CFI year-on-year change?
What is Sarepta Therapeutics annual cash flow from investing activities?
The current annual CFI of SRPT is $755.56M
What is the all time high annual CFI for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual cash flow from investing activities is $755.56M
What is Sarepta Therapeutics annual CFI year-on-year change?
Over the past year, SRPT annual cash flow from investing activities has changed by +$921.36M (+555.70%)
What is Sarepta Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of SRPT is -$291.18M
What is the all time high quarterly CFI for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly cash flow from investing activities is $764.12M
What is Sarepta Therapeutics quarterly CFI year-on-year change?
Over the past year, SRPT quarterly cash flow from investing activities has changed by -$509.97M (-233.08%)
What is Sarepta Therapeutics TTM cash flow from investing activities?
The current TTM CFI of SRPT is $245.59M
What is the all time high TTM CFI for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM cash flow from investing activities is $755.56M
What is Sarepta Therapeutics TTM CFI year-on-year change?
Over the past year, SRPT TTM cash flow from investing activities has changed by +$205.09M (+506.38%)